Bcl-2 Activates the Transcription Factor NFκB through the Degradation of the Cytoplasmic Inhibitor IκBα

This publication has 40 references indexed in Scilit:

• Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.
  Journal of Clinical Investigation, 1997
• An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
  Science, 1996
• Pleiotropic effects of Bcl-2 on transcription factors in T cells: potential role of NF-_KB p50–p50 for the anti-apoptotic function of Bcl-2
  International Immunology, 1995
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
  Cell, 1993
• Southwestern Internal Medicine Conference: Prospects for Gene Therapy of Ischemic Heart Disease
  The Lancet Healthy Longevity, 1993
• Tumor necrosis factor-α, interleukin 1, and phorbol myristate acetate are independent activators of NF-κB which differentially activate T cells
  Cytokine, 1991
• DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide
  Cell, 1991
• Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal
  Cell, 1990
• A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
  Genes & Development, 1989
• Multiple nuclear factors interact with the immunoglobulin enhancer sequences
  Cell, 1986